HOME >> MEDICINE >> NEWS
Molecular change occurring during brain tumor progression also evident in breast cancer

LOS ANGELES (May 3, 2005) -- A molecular change that takes place during the progression of malignant brain tumors also occurs in breast cancer, according to a study conducted at Cedars-Sinai's Maxine Dunitz Neurosurgical Institute. The shift appears to be part of a process that enables tumors to develop the new blood vessels they need to grow rapidly, migrate and invade other tissue.

Although the switch is evident even in an early stage of breast cancer when cells are proliferating but not infiltrating normal tissue, it becomes more pronounced as the cancer progresses to the invasive stage. Therefore, the genes involved and the proteins they produce may become markers that physicians can use to determine disease progression and patient prognosis. They also may become targets for new therapies.

The switch affects proteins called laminins, which are components of the "basement membrane" of blood vessels, a thin mesh-like structure beneath the cells of the blood vessel surface (epithelium). Although the surface cells and the basement membrane are distinct entities, they affect each other through biochemical interactions. In fact, the cells actually influence the composition of the basement membrane, and the membrane, in addition to serving as a scaffold for cell attachment, regulates cell behavior, proliferation and migration.

The laminin molecule is composed of three chains -- designated alpha (), beta (]) and gamma (^) -- that are linked together in various combinations to form 15 known isoforms or types of laminin. Each isoform has distinct characteristics and functions. Isoforms are known to change in normal tissues at various stages of development but they also have been found to shift in the presence of several invasive cancers. This shift coincides with blood vessel changes that encourage tumor growth and metastasis.

Over the past several years, Cedars-Sinai researchers published several articles related to their findings t
'"/>

Contact: Sandy Van
sandy@prpacific.com
1-800-880-2397
Cedars-Sinai Medical Center
4-May-2005


Page: 1 2 3

Related medicine news :

1. Elsevier launches Molecular Oncology
2. Molecular marker may help identify pancreatic cancer, and possibly predict survival time
3. Molecular differences between early and advanced melanomas could provide new drug targets
4. Molecular structure reveals how botulinum toxin attaches to nerve cells
5. Molecular medicine comes to the rescue
6. Molecular switch may turn off immune cells that target HIV
7. Molecular imaging may lead to earlier diagnosis of childhood respiratory virus
8. The Molecular Profiling Institute, Inc. and IBM advance technology
9. Molecular Profiling Institute secures $7.5 million in Series B funding
10. Molecular studies in cancer of the colon
11. Molecular ballet unravels, links proteins so cell can direct own movement

Post Your Comments:
(Date:5/22/2013)... new study suggests that disturbed sleep in adolescents ... greater uncertainly about future success. However, perceived ... to have a protective effect. , Results ... depressed mood and greater uncertainty about future success. ... from teachers were associated with significantly fewer sleep ...
(Date:5/22/2013)... Auburn, AL (PRWEB) May 22, 2013 ... Jr. of Birmingham, Alabama. A University of Alabama graduate, ... its surrounding areas. As a TeethWhiteningforFree.com dentist, he extends ... office for a routine exam and/or check up. Only ... health makes them eligible for whitening treatments. ...
(Date:5/22/2013)... With the health of a growing fetus largely dependent ... that many women become hyperaware of everything that goes into ... on a pregnancy test. At no other time in life ... (like caffeine, alcohol, and nicotine) stronger than during pregnancy. But ... Does this increased awareness during pregnancy extend to the lotions, ...
(Date:5/22/2013)... Peak Solar introduces unique, interactive solar training seminars, which ... make informed buying choices. Research studies tell companies that ... to give them the tools needed to make informed ... Solar training seminars will be introduced onto the website, ... kits . , Poised to help both residential and ...
(Date:5/22/2013)... CA (PRWEB) May 22, 2013 Many problems ... great deal of pain for a patient if left untreated. ... their pain could be easily fixed through occlusal adjustment. ... or neck and back pain should have their dentist check ... change the bite and can lead to problems if the ...
Breaking Medicine News(10 mins):Health News:Parent and teacher support protects teens from sleep problems and depression 2Health News:Dr. James Sanderson, Jr. Of SanDentistry in Hoover, Alabama Joins the TeethWhiteningforFree.com Family 2Health News:Fairhaven Health Launches New PregnancyPlus Natural Deodorant Designed Specifically for Pregnant Women 2Health News:Online Solar Training Seminars Aimed at Informing Consumers 2Health News:Dr. Martin N. Gorman: Make Headaches, Sensitive Teeth and Neck or Back Pain a Thing of the Past 2
(Date:5/22/2013)... , 22. Mai 2013  Grifols, ein ... Barcelona , Spanien, präsentierte ... eine höhere Dosis von PROLASTIN©-C (Alpha1-Proteinasehemmer [human]) ... Alpha1-Antitrypsinmangel (AAT) auf ein Niveau anhebt, das ... Bereichs liegt. ATT-Mangel ist eine lebensbedrohliche, genetische ...
(Date:5/22/2013)... Israel , May 22, 2013  Rosetta ... developer and provider of microRNA-based molecular diagnostics, announces that ... Chief Executive Officer of Rosetta Genomics, will deliver a ... place from June 3-6, 2013 in New York City.  ... 4 th at 2:00 p.m. Eastern time. ...
(Date:5/22/2013)... , May 22, 2013  Medifocus, Inc. (OTCQX: MDFZF and ... , Chief Operating Officer, will present at the Second Annual ... New York City at the Grand ... to begin at 4:00 p.m. EDT and will be available ...   http://wsw.com/webcast/marcum/mfs.v/   For more information and registration, ...
Breaking Medicine Technology:Studie von Grifols zeigt, dass eine höhere Dosis von PROLASTIN-C den Alpha1-PI-Spiegel in Patienten mit AAT-Mangel in den normalen Bereich anhebt 2Studie von Grifols zeigt, dass eine höhere Dosis von PROLASTIN-C den Alpha1-PI-Spiegel in Patienten mit AAT-Mangel in den normalen Bereich anhebt 3Studie von Grifols zeigt, dass eine höhere Dosis von PROLASTIN-C den Alpha1-PI-Spiegel in Patienten mit AAT-Mangel in den normalen Bereich anhebt 4Rosetta Genomics to Present at the Jefferies 2013 Healthcare Conference 2Rosetta Genomics to Present at the Jefferies 2013 Healthcare Conference 3Medifocus, Inc. to Present At The Second Annual Marcum LLP MicroCap Conference 2Medifocus, Inc. to Present At The Second Annual Marcum LLP MicroCap Conference 3
Cached News: